ImmuCell
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $10,357 | $7,625 | $5,506 | $6,444 |
Gross Profit | 4,657 | 2,910 | 2,363 | 2,817 |
EBITDA | 2,497 | -2,036 | 543 | 1,296 |
EBIT | 1,969 | -2,742 | -135 | 628 |
Net Income | 1,941 | -2,849 | -139 | 501 |
Net Change In Cash | 10,357 | 7,625 | 5,506 | 6,444 |
Free Cash Flow | 3,395 | 310 | -1,776 | 1,446 |
Cash | 6,812 | 3,807 | 3,886 | 5,998 |
Basic Shares | 9,045 | 9,046 | 9,046 | 9,031 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $27,644 | $26,493 | $17,471 | $18,568 |
Gross Profit | 11,445 | 7,941 | 4,396 | 7,649 |
EBITDA | 2,140 | 1,066 | -2,504 | 188 |
EBIT | -589 | -1,620 | -5,221 | -2,299 |
Net Income | -1,040 | -2,156 | -5,774 | -2,494 |
Net Change In Cash | 27,644 | 26,493 | 17,471 | 18,568 |
Free Cash Flow | 1,224 | -107 | -6,566 | -5,519 |
Cash | 3,807 | 3,758 | 978 | 5,792 |
Basic Shares | 9,026 | 8,167 | 7,747 | 7,745 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0.21 |
2025-12-31 | -$0.31 |
2025-09-30 | -$0.02 |
2025-06-30 | $0.06 |